NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Bakkt Acquires DTR: Analyst Sees Strong Growth Ahead

Bakkt agrees to acquire Distributed Technologies Research in $150M stock deal. Clear Street analyst rates it a Buy with $39 target as stablecoin business expands.

Bakkt Acquires DTR: Analyst Sees Strong Growth Ahead
Credit: Bakkt Holdings
Already have an account? Sign in.
01/12/2026 · 2:52 PM
BKKT
/ Read more

Feed↓

Goldman Sachs Upgrades Arcus Biosciences to Buy on Strong Cancer Drug Data
01/12/2026 · 4:55 PM

Goldman Sachs Upgrades Arcus Biosciences to Buy on Strong Cancer Drug Data

Goldman Sachs upgraded Arcus Biosciences to Buy, raising its price target to $28 on promising results for its lead cancer drug Casdatifan.

/ Subscriber only
Solid Biosciences Wins FDA Orphan Drug Status for Friedreich's Ataxia Treatment
01/12/2026 · 4:29 PM

Solid Biosciences Wins FDA Orphan Drug Status for Friedreich's Ataxia Treatment

Solid Biosciences receives FDA Orphan Drug designation for SGT-212, a dual-route gene therapy treating Friedreich's ataxia, with first patient dosed in clinical trial.

/ Subscriber only
Supreme Court Denies Hertz Appeal: $320M Owed to Bondholders After COVID Bankruptcy
01/12/2026 · 2:35 PM

Supreme Court Denies Hertz Appeal: $320M Owed to Bondholders After COVID Bankruptcy

US Supreme Court rejects Hertz's challenge to $320M+ bondholder payment ruling from its 2020 COVID bankruptcy, requiring make-whole premiums and higher interest rates.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe